20
scientific programme overview
Plenary Hall A
level 1
Ballroom A
level 1
Ballroom B
level 1
Ballroom C
level 1
Room 11
level 2
PL-03
The endocannabi-
noid system–a
fifty years trip
Break
S-11
The potential of
high-risk studies
to inform early
intervention in
bipolar disorder
S-12
Targeting the
endocannabi-
noid system to
treat psychiatric
disorders: Clinical
and pre-clinical
evidence
S-13
The epigenetic
embedding of
early life stress
in humans and
animal models
S-14
Prefrontal
norepinephrine
in arousal and ex-
ecutive function
Break
Break
SA-03
Impact of mainte-
nance treatment
on the natural
illness progression
in schizophrenia
SA-04
Challenges in the
management of
bipolar disorder:
Focus on unmet
needs
PL-04
Brain science
using iPS cell
technology non-
human primates
Break
S-16
New basic and
clinical develop-
ments for treat-
ment resistant
depression
S-17
Novel glutama-
tergic treatment
approaches for
schizophrenia:
Pharmacology,
imaging and clini-
cal trials
S-18
Breakthroughs in
psychopharmacol-
ogy for prevention
and treatment of
PTSD
S-19
The psycho-
pharmacology of
aggression: From
biomarkers to
therapeutics
Poster Sessions in Exhibition Hall B
P-20 – P-38, RA
Late Breaking Poster Session LP-02
SC-02
CDS in PD
Hall
Time
09:00
09:45
10:00
12:00
12:15
13:45
14:00
14:45
15:00
17.00
17:15
18:45
